ࡱ> '` snbjbj{P{P ::qf4hdkkk=??????$nhckkcxԡԡԡ* =ԡ=ԡԡ4 P%}>,<ʡ|kZŔ@ԡ49kkkccʡ kkkD,$PD,P Electronic file material, ArticlePlus Table 1. Demographic data of included studies. Author (Year)Study DesignPopulationCondition and TreatmentProphylaxisBoakye (2008)Retrospective cohort National Inpatient Sample databaseN = 58,115 Mean age: 51% were 45-64 yrs 42% maleCervical spondylotic myelopathy Spinal fusion surgery NROtero-Fernandez (2008)Prospective cohortN = 225 Mean age: NR for spine surgery* NR% maleVarious spine conditions Spine surgeryDaily bemiparin (LMWH) 2500 IU (moderate risk) or 3500 IU (high risk)Piasecki (2008)Prospective cohortN = 66 Mean age: 52 yrs 14% maleScoliosis (n = 40) or revision surgery (n = 26) after failed fusion or laminectomy Combined anterior/posterior fusion spine surgery;Mechanical prophylaxis with foot pumps during and post-opSchizas (2008)Prospective cohortN = 270 Mean age: 44 yrs NR% maleSpinal stenosis (n = 77), fractures or posttraumatic deformities (n = 57), DDD (n = 37), herniated discs (n = 26), spondylolisthesis (n = 27), scoliosis (n = 23), tumors (n = 8), infections (n = 8), rheumatoid arthritis (n = 7) Anterior and/or posterior spinal fusions, discectomies and/or decompression surgeriesIPCs and enoxoparin (LMWH), 20mg daily for 3 days postop, then 40mg daily until dischargeChin (2007)Prospective and retrospective cohortN = 89 Median age: cases 36 yrs controls 47 yrs 54% maleLumbar disc disease Lumbar microdiscectomy 30 mg ketorolac (Toradol) immediately before wound closure (n = 44) or none (n = 45)Patel (2007) Retrospective cohortN = 84 Mean age: 59 yrs 35% maleDegenerative disease Elective lumbar and thoracic spinal fusionNREpstein (2006)Retrospective cohortN = 139 Mean age: 53 yrs 56% maleStenosis with instability, spondylolisthesis Multilevel lumbar laminectomies with instrumented fusionIPCs used for prophylaxisAwad (2005)Retrospective case-controlN = 134 Mean age: cases 60 yrs controls 55 yrs 52% maleVarious spine conditions All levels of spinal surgery. (Cases (n = 32) developed post-operative spinal epidural hematoma, controls were matched by complexity of spinal surgery procedure and time period.)NR Epstein (2005) Retrospective cohort Single-level, N = 100 Mean age: 46 yrs 57% male Multilevel, N = 100 Mean age: 55 yrs 65% maleSpondylosis, stenosis, and/or OPLL Single-level anterior corpectomy/fusion (ACF) (n = 100) and multilevel ACF/posterior fusion (n = 100) Intermittent compression stockings (IPCs)Brau (2004)Retrospective cohortN = 1310 Age range: 18-84 yrs 49% maleLumbar disc disease ALIF or total disc replacement using mini-open, retroperitoneal approach NRGerlach (2004)Retrospective cohortN = 1954 Mean age: NR NR% maleSpinal stenosis or disc herniation (n = 1618), stabilization (n = 55), tumor (n = 182), infection (n = 57), fractures (n = 28), hematoma (n = 14) Cervical, thoracic and lumbar spinal proceduresReceived intra- and post-operative IPCs AND postop daily 0.3ml nadroparin calcium, 2850 IU anti-XaScaduto (2003)Prospective cohortN = 119 Mean age: 44 yrs 44% maleLumbar disc disease ALIF (n = 88) or PLF (n = 31) Brau (2002)Retrospective cohortN = 686 Age range: 19-84 yrs 50.3% maleLumbar disc disease ALIF using mini-open, retroperitoneal approach NRLee (2000)Retrospective cohortN = 313 Mean age: 48 yrs 49% maleStenosis (n = 101), spondylolisthesis (n = 68), herniated disc (n = 8), scoliosis (n = 13), OPLL (n = 2), CSM (n = 25), infection (n = 26), fracture (n = 62), tumor (n = 8) Multilevel anterior and/or posterior decompression and/or fusions No antithrombotic prophylaxisOda (2000)Retrospective cohortN = 110 Mean age: 59 yrs 58% maleStenosis (n = 20), scoliosis (n = 8), arthrodesis (n = 10), herniated disc (n = 24), scoliosis, OPLL (n = 11), myelopathy (n = 34), tumor (n = 3) Posterior spinal surgery.No mechanical or medical antithrombotic prophylaxis Dearborn (1999) Prospective and retrospective cohortProspective, N = 116 Mean age: 46 yrs 29% male Retrospective, N = 267 Mean age: 48 yrs 28% maleScoliosis, stenosis, spondylolisthesis, kyphosis, pseudoarthrosis, or other degenerative spinal conditions Anterior, posterior or combined ant/post spinal reconstruction surgeryThigh-length elastic antiembolism stockings and IPCs during and postop; no pharmacologic anticoagulationRajaraman (1999)Prospective cohortN = 60 Mean age: 42 yrs 52% maleDiscogenic back pain (n = 33), failed back syndrome (n = 11), pseudoarthrosis, (n = 5) postlaminectomy syndrome (n = 4), spondylolisthesis (n = 3), fracture (n = 2), tumor (n = 2) ALIF via retroperitoneal (n = 57) or transperitoneal (n = 3)NRRokito (1996)Prospective cohort N = 110 Mean age: 44 yrs 40% male lumbar disorder (n = 86), scoliosis (n = 14), thoracic disorder (n = 7), cervical disorder (n = 1), trauma (n = 2) Anterior and/or posterior spinal fusions and/or decompression surgery Thigh-high compression stockings (n = 42), compression stockings and thigh-length IPCs (n = 33), or compression stockings and 10mg Coumadin on the evening before surgery and daily postop (n = 35)Smith (1994)Prospective cohortN = 317 Mean age: NR NR% maleDegenerative spine disease (n = 172), spondylolisthesis (n = 31) spinal trauma (n = 34), scoliosis (n = 77), infection (n = 3) Spinal surgery  Thigh-length IPCs, no medical antithrombotic prophylaxisFerreea (1993)Prospective cohortN = 86 Mean age: 43 yrs 53% maleScoliosis, degenerative disc disease, spondylolisthesis, instability Lumbar (n = 78) or thoracic (n = 8) decompression and/or fusion spineIPCsWest (1992)Prospective cohortN = 41 Mean age: 38 yrs NR% maleSpinal deformity (n = 14), trauma (n = 16), degenerative spine disease (n = 11) Anterior and/or posterior instrumented fusion No preoperative or intraoperative thrombotic prophylaxis; used postop compression stockingsRamirez (1989)Prospective cohortN = 35,708 Mean age: NR NR% male Commission on Professional and Hospital Activities DatabaseLumbar disc displacement or degeneration, no history of previous surgery; Lumbar discectomy at one or two levels without fusionNRUden (1979)Prospective cohortN = 1229 Mean age: 57 yrs 33% maleScoliosis Fusion using Harrington rodsNRGruber (1984)Prospective cohortN = 50 Heparin Mean age: 47 yrs 57% male Placebo Mean age: 45 yrs 65% maleHerniated lumbar disc (treatments)2500 IU miniheparin-dihydroergotamine two times daily (n = 25) or placebo (n = 20), beginning 2 hrs preoperatively and continuing at least 7 days or until hospital dischargeVoth (1992)Prospective cohortN = 179 LMWH Mean age: 53 yrs 44% male HDHE Mean age: 53 yrs 45% male (conditions) Lumbar-vertebral disc procedures Fenestration (n = 166) Hemilaminectomy (n = 7) Laminectomy (n = 3) Sequestrotomy (n = 1) NR (n = 2)1500 U-aPTT LMWH plus dihydroergotamine 0.5 mg once daily plus placebo injection daily (n = 87) or 5000 U heparin plus dihydroergotamine 0.5 mg twice a day (n = 92), beginning 2 hrs preoperatively and continued for at least 7 daysFereeb (1993)Prospective cohortN = 185 Elastic compression: Mean age: 43 yrs NR% male Pneumatic compression: Mean age: 50 yrs NR% maleLaminectomy or laminotomy (n = 84); posterior spinal fusion with or without laminectomy or laminotomy (n = 101)Elastic compression stockings (n = 74) or intermittent pneumatic compression (n = 111)Flinn (1996)Prospective cohortN = 2643 Mean age: 58 yrs 52% maleCraniotomies for treatment of neoplasms or cerebrovascular disorders (n = 1439); ventriculoperitoneal or other shunting procedures (n = 299); cervical or lumbar spinal surgeries (n = 454)Elastic stockings and IPCWood (1997) Prospective cohortN = 136 Plexi Pulse: Mean age: 39 yrs 52% male SCD: Mean age: 40 yrs 66% male Major reconstructive spinal surgeries defined as anterior and/or posterior thoracic, lumbar, or thoracolumbar spinal fusions and/or multilevel decompression surgeryThigh-high pneumatic compression wraps or pneumatic foot-compression wrapsNelson (1996)Prospective cohortN = 117 Mean age: NR NR% maleDegenerative spinal disease; posterior lumbar decompression with fusion and fixationTED stockings and acetylsalicyclic acid (ASA) 600 mg bid (n = 60) or TED and pneumatic compression boots and ASA 600 mg bid (n = 57) ALIF = anterior lumbar interbody fusion ; CSM = cervical spondylotic myelopathy; DDD = degenerative disc disease; DVT = deep vein thrombosis; INR = International Normalized Ratio; IPCs = intermittent compression stockings; LMWH = low-molecular weight heparin; NR = not reported; OPLL = ossification of the posterior longitudinal ligament; PE = pulmonary embolism. *Study included orthopedic surgery patients; data reported for spine surgery only. Table 2. Frequencies of thromboembolism by spine condition in patients whose chemical antithrombotic prophylaxis was not reported. Spine Condition treated AuthorDVT n/N (%) PE n/N (%)Fatal PE n/N (%)DegenerativeBoakye (2008) ADDIN EN.CITE Boakye200894949417Boakye, M.Patil, C. G.Santarelli, J.Ho, C.Tian, W.Lad, S. P.Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA.Cervical spondylotic myelopathy: complications and outcomes after spinal fusionNeurosurgeryNeurosurgery455-61; discussion 461-2622AdolescentAdultAge FactorsAgedAged, 80 and overCervical VertebraeChildChild, PreschoolComorbidityFemaleHumansInfantInfant, NewbornMaleMiddle AgedMultivariate Analysis*Postoperative ComplicationsSpinal Cord Diseases/*surgerySpinal Fusion/*adverse effectsSpondylolysis/*surgeryTreatment Outcome2008Feb1524-4040 (Electronic)18382324http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18382324 eng8 Patel (2007) ADDIN EN.CITE  ADDIN EN.CITE.DATA 10 Brau (2002) ADDIN EN.CITE Brau200210110110117Brau, S. A.Department of Surgery, University of Southern California School of Medicine, 501 E. Handy St., Suite 424, Inglewood, CA 90301, USA. salvo@labridge.comMini-open approach to the spine for anterior lumbar interbody fusion: description of the procedure, results and complicationsSpine J216-2323AdultAgedFemaleHumansIntervertebral Disk/ surgeryLumbar Vertebrae/ surgeryMaleMiddle AgedRetrospective StudiesRisk FactorsSpinal Fusion/ adverse effects/ methods2002May-Jun1529-9430 (Print)145894969 Ramirez (1989) ADDIN EN.CITE Ramirez198910210210217Ramirez, L. F.Thisted, R.Department of Neurosurgery, University of Wisconsin, Madison.Complications and demographic characteristics of patients undergoing lumbar discectomy in community hospitalsNeurosurgeryNeurosurgery226-30; discussion 230-1252DemographyHospitals, CommunityHumansIntervertebral Disk/*surgeryIntraoperative Complications/epidemiology/mortalityLumbosacral RegionPostoperative Complications/epidemiology/mortalityUnited States1989Aug0148-396X (Print)2770987http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2770987 eng7 Scaduto (2003)--------- 2/84 (2.4) 7/686 (1.0) --------- 2/88 (2.3)407/58115 (0.7) --------- 0/686 (0.0) 38/35708 (0.11) ------------------ --------- --------- 4/35708 (0.01) ---------DeformityUden (1979) ADDIN EN.CITE Uden197910710710717Uden, A.Thromboembolic complications following scoliosis surgery in ScandinaviaActa Orthop Scand175-8502AdolescentAdultFemaleFemoral VeinFollow-Up StudiesHumansIliac VeinMalePostoperative Complications/ epidemiologyPulmonary Embolism/ epidemiologyScoliosis/ surgeryThrombophlebitis/ epidemiology1979Apr0001-6470 (Print)43358068/1229 (0.65)1/1229 (0.08)1/1229 (0.08)Multiple spine conditionsRajaraman (1999) ADDIN EN.CITE  ADDIN EN.CITE.DATA 41/60 (1.7)------------------ Table 3. Level of Evidence grade for studies reporting rate of thromboembolic events in spine surgery. Methodological PrincipleBoakye 2008Brau 2002Dearborn 1999Epstein 2005Epstein 2006Ferreea 1993Ferreeb 1993Ferree 1994Lee 2000Nelson 1996Study designProspective cohort study(((((Retrospective cohort study((((((Case controlPatients at similar point in the course of their disease or treatment((((((((((Patients followed long enough for outcomes to occur((((((((((Complete follow-up of >80%((((((((((Controlling for extraneous prognostic factors*Evidence LevelIIIIIIII-IIIIIIIIIIIIIIIIIIII Methodological PrincipleOda 2000Patel 2007Piasecki 2008Rajaraman 1999Ramirez 1989Scaduto 2003Smith 1994Uden 1979West 1992Wood 1997Flinn 1996Study designProspective cohort study((((((((Retrospective cohort study(((Case ControlPatients at similar point in the course of their disease or treatment(((((((((((Patients followed long enough for outcomes to occur(((((((((((Complete follow-up of >80%(((((((((((Controlling for extraneous prognostic factors*(Evidence LevelIIIIIIIIIIIIIIIIIIIIIIII Table 4. Level of Evidence grade for studies reporting significant hemorrhage secondary to anticoagulant use. Methodological PrincipleChin 2007Gerlach 2004Otero-Fernandez 2008Rokito 1996Shizas 2008Gruber 1984Voth 1992Study designProspective cohort study((((((Retrospective cohort study(Case ControlPatients at similar point in the course of their disease or treatment(((((((Patients followed long enough for outcomes to occur(((((((Complete follow-up of >80%(((((((Controlling for extraneous prognostic factorsEvidence LevelIIIIIIIIIIIIIII Table 1. Demographic data of included studies. Author (Year)Study DesignPopulationCondition and TreatmentProphylaxisBoakye (2008)Retrospective cohort National Inpatient Sample databaseN = 58,115 Mean age: 51% were 45-64 yrs 42% maleCervical spondylotic myelopathy Spinal fusion surgery NROtero-Fernandez (2008)Prospective cohortN = 225 Mean age: NR for spine surgery* NR% maleVarious spine conditions Spine surgeryDaily bemiparin (LMWH) 2500 IU (moderate risk) or 3500 IU (high risk)Piasecki (2008)Prospective cohortN = 66 Mean age: 52 yrs 14% maleScoliosis (n = 40) or revision surgery (n = 26) after failed fusion or laminectomy Combined anterior/posterior fusion spine surgery;Mechanical prophylaxis with foot pumps during and post-opSchizas (2008)Prospective cohortN = 270 Mean age: 44 yrs NR% maleSpinal stenosis (n = 77), fractures or posttraumatic deformities (n = 57), DDD (n = 37), herniated discs (n = 26), spondylolisthesis (n = 27), scoliosis (n = 23), tumors (n = 8), infections (n = 8), rheumatoid arthritis (n = 7) Anterior and/or posterior spinal fusions, discectomies and/or decompression surgeriesIPCs and enoxoparin (LMWH), 20mg daily for 3 days postop, then 40mg daily until dischargeChin (2007)Prospective and retrospective cohortN = 89 Median age: cases 36 yrs controls 47 yrs 54% maleLumbar disc disease Lumbar microdiscectomy 30 mg ketorolac (Toradol) immediately before wound closure (n = 44) or none (n = 45)Patel (2007) Retrospective cohortN = 84 Mean age: 59 yrs 35% maleDegenerative disease Elective lumbar and thoracic spinal fusionNREpstein (2006)Retrospective cohortN = 139 Mean age: 53 yrs 56% maleStenosis with instability, spondylolisthesis Multilevel lumbar laminectomies with instrumented fusionIPCs used for prophylaxisAwad (2005)Retrospective case-controlN = 134 Mean age: cases 60 yrs controls 55 yrs 52% maleVarious spine conditions All levels of spinal surgery. (Cases (n = 32) developed post-operative spinal epidural hematoma, controls were matched by complexity of spinal surgery procedure and time period.)NR Epstein (2005) Retrospective cohort Single-level, N = 100 Mean age: 46 yrs 57% male Multilevel, N = 100 Mean age: 55 yrs 65% maleSpondylosis, stenosis, and/or OPLL Single-level anterior corpectomy/fusion (ACF) (n = 100) and multilevel ACF/posterior fusion (n = 100) Intermittent compression stockings (IPCs)Brau (2004)Retrospective cohortN = 1310 Age range: 18-84 yrs 49% maleLumbar disc disease ALIF or total disc replacement using mini-open, retroperitoneal approach NRGerlach (2004)Retrospective cohortN = 1954 Mean age: NR NR% maleSpinal stenosis or disc herniation (n = 1618), stabilization (n = 55), tumor (n = 182), infection (n = 57), fractures (n = 28), hematoma (n = 14) Cervical, thoracic and lumbar spinal proceduresReceived intra- and post-operative IPCs AND postop daily 0.3ml nadroparin calcium, 2850 IU anti-XaScaduto (2003)Prospective cohortN = 119 Mean age: 44 yrs 44% maleLumbar disc disease ALIF (n = 88) or PLF (n = 31) Brau (2002)Retrospective cohortN = 686 Age range: 19-84 yrs 50.3% maleLumbar disc disease ALIF using mini-open, retroperitoneal approach NRLee (2000)Retrospective cohortN = 313 Mean age: 48 yrs 49% maleStenosis (n = 101), spondylolisthesis (n = 68), herniated disc (n = 8), scoliosis (n = 13), OPLL (n = 2), CSM (n = 25), infection (n = 26), fracture (n = 62), tumor (n = 8) Multilevel anterior and/or posterior decompression and/or fusions No antithrombotic prophylaxisOda (2000)Retrospective cohortN = 110 Mean age: 59 yrs 58% maleStenosis (n = 20), scoliosis (n = 8), arthrodesis (n = 10), herniated disc (n = 24), scoliosis, OPLL (n = 11), myelopathy (n = 34), tumor (n = 3) Posterior spinal surgery.No mechanical or medical antithrombotic prophylaxis Dearborn (1999) Prospective and retrospective cohortProspective, N = 116 Mean age: 46 yrs 29% male Retrospective, N = 267 Mean age: 48 yrs 28% maleScoliosis, stenosis, spondylolisthesis, kyphosis, pseudoarthrosis, or other degenerative spinal conditions Anterior, posterior or combined ant/post spinal reconstruction surgeryThigh-length elastic antiembolism stockings and IPCs during and postop; no pharmacologic anticoagulationRajaraman (1999)Prospective cohortN = 60 Mean age: 42 yrs 52% maleDiscogenic back pain (n = 33), failed back syndrome (n = 11), pseudoarthrosis, (n = 5) postlaminectomy syndrome (n = 4), spondylolisthesis (n = 3), fracture (n = 2), tumor (n = 2) ALIF via retroperitoneal (n = 57) or transperitoneal (n = 3)NRRokito (1996)Prospective cohort N = 110 Mean age: 44 yrs 40% male lumbar disorder (n = 86), scoliosis (n = 14), thoracic disorder (n = 7), cervical disorder (n = 1), trauma (n = 2) Anterior and/or posterior spinal fusions and/or decompression surgery Thigh-high compression stockings (n = 42), compression stockings and thigh-length IPCs (n = 33), or compression stockings and 10mg Coumadin on the evening before surgery and daily postop (n = 35)Smith (1994)Prospective cohortN = 317 Mean age: NR NR% maleDegenerative spine disease (n = 172), spondylolisthesis (n = 31) spinal trauma (n = 34), scoliosis (n = 77), infection (n = 3) Spinal surgery  Thigh-length IPCs, no medical antithrombotic prophylaxisFerreeb (1993)Prospective cohortN = 86 Mean age: 43 yrs 53% maleScoliosis, degenerative disc disease, spondylolisthesis, instability Lumbar (n = 78) or thoracic (n = 8) decompression and/or fusion spineIPCsWest (1992)Prospective cohortN = 41 Mean age: 38 yrs NR% maleSpinal deformity (n = 14), trauma (n = 16), degenerative spine disease (n = 11) Anterior and/or posterior instrumented fusion No preoperative or intraoperative thrombotic prophylaxis; used postop compression stockingsRamirez (1989)Prospective cohortN = 35,708 Mean age: NR NR% male Commission on Professional and Hospital Activities DatabaseLumbar disc displacement or degeneration, no history of previous surgery; Lumbar discectomy at one or two levels without fusionNRUden (1979)Prospective cohortN = 1229 Mean age: 57 yrs 33% maleScoliosis Fusion using Harrington rodsNRGruber (1984)Prospective cohortN = 50 Heparin Mean age: 47 yrs 57% male Placebo Mean age: 45 yrs 65% maleHerniated lumbar disc (treatments)2500 IU miniheparin-dihydroergotamine two times daily (n = 25) or placebo (n = 20), beginning 2 hrs preoperatively and continuing at least 7 days or until hospital dischargeVoth (1992)Prospective cohortN = 179 LMWH Mean age: 53 yrs 44% male HDHE Mean age: 53 yrs 45% male (conditions) Lumbar-vertebral disc procedures Fenestration (n = 166) Hemilaminectomy (n = 7) Laminectomy (n = 3) Sequestrotomy (n = 1) NR (n = 2)1500 U-aPTT LMWH plus dihydroergotamine 0.5 mg once daily plus placebo injection daily (n = 87) or 5000 U heparin plus dihydroergotamine 0.5 mg twice a day (n = 92), beginning 2 hrs preoperatively and continued for at least 7 daysFereea (1993)Prospective cohortN = 185 Elastic compression: Mean age: 43 yrs NR% male Pneumatic compression: Mean age: 50 yrs NR% maleLaminectomy or laminotomy (n = 84); posterior spinal fusion with or without laminectomy or laminotomy (n = 101)Elastic compression stockings (n = 74) or intermittent pneumatic compression (n = 111)Flinn (1996)Prospective cohortN = 2643 Mean age: 58 yrs 52% maleCraniotomies for treatment of neoplasms or cerebrovascular disorders (n = 1439); ventriculoperitoneal or other shunting procedures (n = 299); cervical or lumbar spinal surgeries (n = 454)Elastic stockings and IPCWood (1997) Prospective cohortN = 136 Plexi Pulse: Mean age: 39 yrs 52% male SCD: Mean age: 40 yrs 66% male Major reconstructive spinal surgeries defined as anterior and/or posterior thoracic, lumbar, or thoracolumbar spinal fusions and/or multilevel decompression surgeryThigh-high pneumatic compression wraps or pneumatic foot-compression wrapsNelson (1996)Prospective cohortN = 117 Mean age: NR NR% maleDegenerative spinal disease; posterior lumbar decompression with fusion and fixationTED stockings and acetylsalicyclic acid (ASA) 600 mg bid (n = 60) or TED and pneumatic compression boots and ASA 600 mg bid (n = 57) DVT = Deep vein thrombosis; PE = Pulmonary embolism NR = no report INR = International Normalized Ratio Ossification of the posterior longitudinal ligament (OPLL) CSM = cervical spondylotic myelopathy LMWH = low-molecular weight heparin DDD = degenerative disc disease Intermittent compression stockings (IPCs) Anterior lumbar interbody fusion (ALIF) *Study included orthopedic surgery patients; data reported for spine surgery only &'01W~ % < > X n o ? A B G t x C J ~    , 0 J N P Q  , 2 3 H I U Ҿh(hI-CJaJmHsHhI-CJaJh(hI-CJaJhI-5CJaJh(hI-5CJaJhTNhI-5 hI-5hI-CJaJh:PhI-5CJaJB&'W^els~ $IfgdI-$If]^gdI-$$If]^a$gdI-8|@&^8`|gdI- 0^`0gdI- qnrn='''$$If]^a$gdI-kd$$Ifl4rLv)*Fb2 0*4 lapytI-  = T W $IfgdI-$If]^gdI-W X h o O999$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI- " $IfgdI-$If]^gdI-" # 3 A H O999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-H O ` i ( $IfgdI-$If]^gdI-( ) 8 D K O999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-K S d m Q  $IfgdI- $If]gdI-$If]^gdI-   , 3 O999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-3 ; H U f o $IfgdI-H$If]^HgdI-$If]^gdI- U V o JL%AM_`z'opv!OS} l*.13 hl7hI-CJaJh(hI-CJaJmHsHh?=ZhI-CJaJh8)hI-CJaJmH sH h(hI-CJaJhI-CJaJI O999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI--6Kvy $IfgdI-$If]^gdI-yzO;%;$$If]^a$gdI-$$If]^a$gdI-kd|$$IflQrLv)*Fb2 0*4 laytI-&@ $IfgdI-$If]^gdI-@AMhpO99($If]^gdI-$$If]^a$gdI-kd_$$IflQrLv)*Fb2 0*4 laytI-p{qt $IfgdI-H$If]^HgdI-$If]^gdI-tu~O9999$$If]^a$gdI-kdB$$IflQrLv)*Fb2 0*4 laytI-  $IfgdI-$If]^gdI-$If]^gdI- O99($If]^gdI-$$If]^a$gdI-kd%$$IflQrLv)*Fb2 0*4 laytI-Y\]5kd $$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-]l2b $IfgdI-$If]^gdI-$$If]^a$gdI-O999$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI- => $IfgdI-$If]^gdI-"$(/248Z_-Adu{|.FIK  VZuy *.CV|X\9h@59hI-CJaJh@59hI-CJaJmHsHhl7hI-CJaJh(hI-CJaJhI-CJaJO>?K`hO99($If]^gdI-$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI-h}5kd $$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI- ! $IfgdI-$If]^gdI-$$If]^a$gdI-!"-BJO99($If]^gdI-$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI-J[dEF5kdw $$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-FOW|J $IfgdI-$If]^gdI-$$If]^a$gdI-  &O99($If]^gdI-$$If]^a$gdI-kdZ$$IflQrLv)*Fb2 0*4 laytI-&7@14 $If]gdI- $IfgdI-$If]^gdI-45CW_O99($If]^gdI-$$If]^a$gdI-kd=$$IflQrLv)*Fb2 0*4 laytI-_pyz{|6 $IfgdI- $If]gdI-$If]^gdI-#O99($If]^gdI-$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI-#09 $IfgdI- $If]gdI-$If]^gdI-%,O99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-  $i  = R g t !!!!!!""######$$~$$$$$%%%`'r' ($(l(m(u(俻hI-hhI-CJaJhc7hI-CJaJhl7hI-CJaJmHsHhI-CJaJhI-CJH*aJh(hI-CJaJF,=F5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-i $IfgdI-$If]^gdI-$$If]^a$gdI-"O99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-"/8t $IfgdI-x$If]^gdI-$If]^gdI-  ! O99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-! 3 < F c f g 5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-g n u ! $IfgdI-$If]^gdI-$$If]^a$gdI- !!!!!O99($If]^gdI-$$If]^a$gdI-kdr$$IflQrLv)*Fb2 0*4 laytI-!!!!!" " "":"Q"i"}"""# $IfgdI-$If]^gdI-#####O99($If]^gdI-$$If]^a$gdI-kdU$$IflQrLv)*Fb2 0*4 laytI-#####$$$$ $IfgdI-$If]^gdI-$$$$$O999$$If]^a$gdI-kd8$$IflQrLv)*Fb2 0*4 laytI-$%%%%%%5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-%%%%%&&'&8&A&F&W&`&a&'Q' $IfgdI-$If]^gdI-$If]^gdI-$$If]^a$gdI-Q'R'Y'`'s'O999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-s'{''''k(l(5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-l(m()-*/**********+$@&If^gdI- $$@&Ifa$gdI-"@&^`"gdI-gdI-u(((((((())()+)L)P)q)x)y)))))))+*,*-*8*9**+#+$+222222222222233P8Q8R8S8b8c8ŵŵŵŵ%jhhI-CJUaJmH sH hyGhI-CJH*aJmH sH hI-CJaJmH sH jhI-CJUaJmH sH h?}hI-CJaJmH sH h?}hI-5CJaJhTNhI-5 hI-5hI-CJaJhhI-CJaJ4+ ++22T89>H>R>sdYYYYYK $$@&Ifa$gdI- $@&IfgdI-$@&If^gdI-kd$$Iflr #( t 44 la<ytI-c85>6>7>8>H>??(?)?CCCCC DDD,D-DADBDDDEDFDlDmDnDsDtDuDDDDźzreZrzrhI-0J5CJaJhyhI-0JCJaJhyhI-5 hI-5j%hI-CJUaJhyGhI-CJH*aJhI-CJaJjhI-CJUaJh?}hI-5CJaJh?}hI-CJaJh?}hI-CJaJmH sH hyGhI-CJH*aJmH sH jhI-CJUaJmH sH hI-CJaJmH sH !R>d>u>>>>>>>>>>>??$@&If]gdI-$$@&If]a$gdI-$$@&If]^a$gdI-$@&If]^gdI- $$@&Ifa$gdI- $@&IfgdI-???CCCCq`SS>S<$@&If]^gdI- <$@&IfgdI-<$@&If^gdI-kd#$$Iflr #( t 44 la<ytI-CC DGDXDbDqbWWA$$@&If]^a$gdI- $@&IfgdI-$@&If^gdI-kdp$$$IflCr #( t 44 la<ytI-bDlDmDDDDeXSF x<$IfgdI-gdI- 0^`0gdI-kd".$$Iflr #( t 44 la<ytI- $$@&Ifa$gdI-DDDDDE5E6EF@FAFCFDFFFGFIFJFLFMFOFPFRFSFUFVFFFFFFFڴڴǩڴϞϞhF!hI-CJaJheGhI-CJaJ%h%OhI-B*CJOJQJaJphhI-CJaJhY hI-CJaJh%OhI-B*CJaJph+ jh%OhI-B*CJOJQJaJph>EEEEEEEEEEEEEE8F;F=F@FCFFFIFLFOFRFUF $IfgdI-FfA $$Ifa$gdI- $If^gdI-Ff>=UFVFFFFFFFFFFFFFFFFFFFFFFFFFFfLFfH $$Ifa$gdI- $IfgdI-FfDFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFGGG G/GWGXGqGĸϭϜhI-h%OhI-B*CJaJph h%OhI-5B*CJaJphhF!hI-CJaJh?hI->*CJaJh?hI-CJaJhY hI-CJaJh%OhI-B*CJaJph+ jh%OhI-B*CJOJQJaJph2FGGGGGGGGGGG G/G3G7G>GBGFGIGLGOGSGVGWGXGgdI-Ff(UFfP $$Ifa$gdI- $IfgdI-XGqGzGGGGGGGGGGGGGGHHHHHHHHH $$Ifa$gdI-FfZ$$If]^a$gdI- $IfgdI-qGzGGGGGGGGHHH H H"H#H&H'H(H)H*H+H,H-H.H/H1H2H3H4H5H6H7H8HRHSHTHUHVH]H^HaHcHðáwwwwwwwwlwwwhY hI-CJaJ+ jh%OhI-B*CJOJQJaJphhI-CJaJhI-CJOJQJaJh%OhI-B*CJaJph%h%OhI-B*CJOJQJaJphheGhI-CJaJhI-5B*CJaJph h%OhI-5B*CJaJph#h%OhI-5B*CJ\aJph*H H H#H%H&H(H*H,H.H0H1H3H5H7H8HSHUHWHXHYHZH\H]H_HaHFfTd $If^gdI-Ff_ $$Ifa$gdI-aHbHcHdHqHrHtHuHvHwHxHyHzH{H|H}H~HHHHHHHHH $IfgdI-FfZm $If^gdI-Ffh $$Ifa$gdI-cHdHpHqHtHuH}H~HHHHHHHHHHHHHHHHHHHHHHHHHIIIIII I!I"I#I$I%I&I(I)I+I,I.I/I1I2I4I5I6I7IMIӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟӟh?hI-CJaJ+ jh%OhI-B*CJOJQJaJphhF!hI-CJaJ%h%OhI-B*CJOJQJaJphh%OhI-B*CJaJphheGhI-CJaJhI-CJaJhY hI-CJaJ9HHHHHHIII!I#I%I'I*I-I0I3I6I7IRIUIXI[I^IaIdIgIFf`v $IfgdI-Ffq $$Ifa$gdI-MINIRISITIVIWIYIZI\I]I_I`IbIcIeIfIhIiIkIlInIoIqIrIsItIIIIIIIIIIIIIIٸٸypdhhI-5CJaJhI-5CJaJhI-B*phhI-B*CJaJphh%OhI-B*CJaJph h%OhI-5B*CJaJphhF!hI-CJaJhY hI-CJaJ+ jh%OhI-B*CJOJQJaJphh%OhI-B*CJaJphh?hI-CJaJh?hI->*CJaJ'gIjImIpIsItIIIIIIIIIIIIIIIIIIIIIIFfX $IfgdI-Ffz $$Ifa$gdI-IIIIIIIIVJWJpJ~JJJJJJJJJJJFf$$If]^a$gdI- $IfgdI- *^*`gdI-gdI-Ff~ $$Ifa$gdI-IITJUJVJWJpJ}J~JJJJJJJJJJJJJJJJJJJJJJKKKKKKKK K K KοΟΟΟΟΔ}uffff}f}f} jhI-CJOJQJaJhI-CJaJhI-CJOJQJaJhY hI-CJaJheGhI-CJaJhI-5B*CJaJph#hY hI-5B*CJ\aJphhI-5B*CJ\aJph h9 hI-5B*CJaJphh%OhI-B*phhhI-5CJaJhI-5CJaJ(JJJJJJJ $$Ifa$gdI-JJkd$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI-JJKKKKK K K $$Ifa$gdI- $If^gdI- K KkdD$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI- K&K'K(K)K0K*CJaJh?hI-CJaJhF!hI-CJaJhI-CJOJQJaJ jhI-CJOJQJaJhY hI-CJaJheGhI-CJaJhI-CJaJ> K'K(K*K+K,K-K.K/K $$Ifa$gdI- $If^gdI-/K0Kkd$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI-0K=K>K?K@KAKBKCKDK $$Ifa$gdI- $If^gdI-DKEKkd$$Ifl ִZJVjd 4#&   *  &* &   %    44 lap<ytI-EKKKKKKKKK $$Ifa$gdI- $IfgdI-KKkdl$$Ifl ִZJVjd 4#&   *  &* &   %    44 lap<ytI-KKKKKKKKK $$Ifa$gdI- $IfgdI-KKkdؒ$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI-KLLL L LLLL $$Ifa$gdI- $IfgdI-LLkd6$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI-LBLDLFLGLHLILJLKL $$Ifa$gdI- $IfgdI-KLLLkd$$Ifl ִZJVjd 4#& *&*&%    44 lap<ytI-LL[L^LaLeLhLkLnLqLrLsLtLuLLLLLLL$If]^gdI-$$If]^a$gdI-8|@&^8`|gdI- 0^`0gdI-gdI-Ffؘ $$Ifa$gdI- $IfgdI-LL[L]L^L`LaLgLhLjLkLqLrLuL~LLLLLL MMMMjMsMMMMMMMMNN(N)NNNNNNNNN O OOOOOOP PP%P)P˷h(hI-CJaJmHsHhI-CJaJh(hI-CJaJhI-5CJaJh(hI-5CJaJhTNhI-5 hI-5hI-h?hI-B*CJaJphhI-B*CJaJph heGhI-5B*CJaJph7LLLL4kd$$Ifl4rLv)*Fb2 0*4 lapytI- $IfgdI-LLM8MDMaMjMMMM $IfgdI-$If]^gdI-$$If]^a$gdI- MMMMMO999$$If]^a$gdI-kd)$$IflQrLv)*Fb2 0*4 laytI-MMMNN*NpN $IfgdI-$If]^gdI-pNqNNNNO999$$If]^a$gdI-kd $$IflQrLv)*Fb2 0*4 laytI-NNNN OYaYZZ3ZHZ{ZZZD[E[[[[[[ \|\\\\Z][]g]l]]]]]]]]^^^,^0^;^?^A^B^P^Z^\^`^x^|^^h}hI-CJaJmHsHhl7hI-CJaJh(hI-CJaJhI-CJaJSVVVVVVWWX $IfgdI-$If]^gdI-$$If]^a$gdI-XXX#X6XO999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-6X>XOXXXlXXX $IfgdI-$If]^gdI-XXXXXO99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-XXXXYYY5kdͦ$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-Y*Y?YGYXYaYZQZoZ $IfgdI-$If]^gdI-$$If]^a$gdI-oZpZ{ZZZO99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-ZZZD[^[[[5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-[[[[[[[\$\-\\\H] $IfgdI-$If]^gdI-$$If]^a$gdI- H]I]Z]m]t]O99($If]^gdI-$$If]^a$gdI-kdv$$IflQrLv)*Fb2 0*4 laytI-t]]]B^^^ $If]gdI- $IfgdI-$If]^gdI-^^^^^O99($If]^gdI-$$If]^a$gdI-kdY$$IflQrLv)*Fb2 0*4 laytI-^^^=_>_____@`D`c`h``aaPaQaWaXamaraaaaabb"b#b=b>b?bDbgbbbbbAc_cdc dd`dedddddddd e!eDeEeeef fffffgggggghl7hI-CJaJmHsHhI-CJH*aJh}hI-CJaJh}hI-CJaJmHsHh(hI-CJaJhI-CJaJF^^^^^^=__H` $IfgdI- $If]gdI-$If]^gdI-H`I`V`i`q`O99($If]^gdI-$$If]^a$gdI-kd<$$IflQrLv)*Fb2 0*4 laytI-q`~``aaPa $IfgdI- $If]gdI-$If]^gdI-PaQa`asazaO99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-zaaaab$b%b5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-%b1bEbLb^bgbbbBc $IfgdI-$If]^gdI-$$If]^a$gdI-BcCcRcecpcO99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-pc}ccc dCdFd $IfgdI-x$If]^gdI-$If]^gdI-FdGdSdfdodO99($If]^gdI-$$If]^a$gdI-kdȮ$$IflQrLv)*Fb2 0*4 laytI-oddddddd5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-ddddddddee!e8eEee $IfgdI-$If]^gdI-$$If]^a$gdI- eefffO99($If]^gdI-$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-f f1f:f?fPfYfZfgfffffffg $IfgdI-$If]^gdI-gggggO99($If]^gdI-$$If]^a$gdI-kdq$$IflQrLv)*Fb2 0*4 laytI-gh#h,hChTh]hh$i $IfgdI-$If]^gdI-g\h]hh$i%i>iDi$j>j?jkknlrlllmnsnhhI-CJaJhI-hhI-CJaJh(hI-CJaJhI-CJaJhc7hI-CJaJ$i%i+i2iEiO999$$If]^a$gdI-kdT$$IflQrLv)*Fb2 0*4 laytI-EiNi_ihi$j>j?j5kd7$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-?jDjKjLjMj`jhjujjjjjjjTkk $IfgdI-$If]^gdI-$If]^gdI-$$If]^a$gdI-kkkkkO999$$If]^a$gdI-kd$$IflQrLv)*Fb2 0*4 laytI-kkkk4lll5kd$$IflQrLv)*Fb2 0*4 laytI- $IfgdI-$If]^gdI-llll$m_mmmmmnmnnnonpnqnrnsn 0^`0gdI-gdI-21h:pI-/ =!"#$% 21h:pI-/ =!"#$% 21h:pI-/ =!"#$%  $$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V l40*,5*5F5b552 4apytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If<!vh5(5555#v(#v#v#v:V l t 5(555/ a<ytI-LDPatel200789898917Patel, N.Bagan, B.Vadera, S.Maltenfort, M. G.Deutsch, H.Vaccaro, A. R.Harrop, J.Sharan, A.Ratliff, J. K.Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.Obesity and spine surgery: relation to perioperative complicationsJ Neurosurg SpineJournal of neurosurgery291-764AdultAgedBody Mass IndexFemaleFollow-Up StudiesHumansIncidenceIntraoperative Complications/*epidemiologyLumbar Vertebrae/surgeryMaleMiddle AgedObesity/*epidemiologyParalysis/epidemiologyPostoperative Complications/*epidemiologyPrevalenceRetrospective StudiesRisk FactorsSpinal Diseases/*epidemiology/*surgerySpinal Fusion/statistics & numerical dataThoracic Vertebrae/surgery2007Apr1547-5654 (Print)17436915http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17436915 eng$$If<!vh5(5555#v(#v#v#v:V l t ,5(555/ / a<ytI-$$If<!vh5(5555#v(#v#v#v:V lC t 5(555/ a<ytI- DRajaraman199910410410417Rajaraman, V.Vingan, R.Roth, P.Heary, R. F.Conklin, L.Jacobs, G. B.Division of Neurosurgery, New Jersey Medical School, Newark 07013, USA. rajaraman@sprintmail.comVisceral and vascular complications resulting from anterior lumbar interbody fusionJ Neurosurg60-4911 SupplAdultAgedAutonomic Nervous System Diseases/etiologyBack Pain/surgeryBlood Vessels/injuriesDiskectomy/adverse effects/methodsFemaleFollow-Up StudiesHumansIntervertebral Disk/surgeryIntraoperative Complications/physiopathology/prevention & controlLaminectomy/adverse effectsLumbar Vertebrae/ surgeryMaleMiddle AgedOrthopedic Fixation DevicesPeripheral Nerves/injuriesPostoperative Complications/physiopathology/prevention & controlPseudarthrosis/surgeryRetrospective StudiesSexual Dysfunction, Physiological/etiologySpinal Fractures/surgerySpinal Fusion/ adverse effects/methodsSpinal Neoplasms/surgerySpondylolisthesis/surgerySympathetic Nervous System/physiopathologySyndromeTitanium1999Jul0022-3085 (Print)10419370$$If<!vh5(5555#v(#v#v#v:V l t ,5(555/ / a<ytI-F$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l nsssssssssssssssssssssssssssssssss5', 5~ 5Y5v55*5 / / /  / /  /  / apnsssssssssssssssssssssssssssssssssytI-kd.$$Ifl > ic3"s%~ Yv* nsssssssssssssssssssssssssssssssss5',,,,44 lapnsssssssssssssssssssssssssssssssssytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5',, 5~ 5Y5v55*5 99/  /  / / /  apFytI-Dkd4$$Ifl  > ic3"s%~ &Yv&&*&&5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/  /  / / /  apFytI-Dkd7$$Ifl  > ic3"s%~ &Yv&&*&&5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/  /  / / /  apFytI-Dkd;$$Ifl  > ic3"s%~ &Yv&&*&&5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/  /  / / /  /  apFytI-Dkd?$$Ifl  > ic3"s%~  &Y v & &* & &     5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/ /  /  / /  /  apFytI-Dkd^C$$Ifl  > ic3"s%~ &Y v & &* & &     5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/ /  / / / /  /  apFytI-Dkd8G$$Ifl  > ic3"s%~ &Yv&&*&&5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/ / / /  /  / / apFytI-Dkd K$$Ifl  > ic3"s%~ &Yv&&*&&5',,,,44 lapFytI-$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l 5', 5~ 5Y5v55*5 99/ / /  / / /  apFytI-DkdO$$Ifl  > ic3"s%&~ &Yv&&*&&5',,,,44 lapFytI-D$$If!v h5~ 5Y5v55*5555 5 5 #v~ #vY#vv#v#v*#v :V l  nsssssssssssssssssssssssssssssssss5', 5~ 5Y5v55*5 99/ /  / / /  /  apnsssssssssssssssssssssssssssssssssytI-kdR$$Ifl  > ic3"s%~ &Yv&&*&& nsssssssssssssssssssssssssssssssss5',,,,44 lapnsssssssssssssssssssssssssssssssssytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l  xssssssssssssssssssssssssssssssssssss), 5~ 55v55855*5 5 v5 5 v9 /  /  /  / agcpxssssssssssssssssssssssssssssssssssssytI-<kd X$$Ifl   > N  X "%(~ &v&&8&&*&&&vv xssssssssssssssssssssssssssssssssssss)000044 lagcpxssssssssssssssssssssssssssssssssssssytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kd]$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kdlb$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kdf$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  /  agcpdytI-kddk$$Ifl   > N  X "%(~   &v & &8 & &* & & &v  v )000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  /  /  / /  agcpdytI-kdo$$Ifl   > N  X "%(~  &v & &8 & &* & & &v  v )000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kdxt$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kdx$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l ), 5~ 55v55855*5 5 v5 5 v9 /  / /  /  agcpdytI-kdp}$$Ifl   > N  X "%(~ &v&&8&&*&&&vv)000044 lagcpdytI-$$If!v h5~ 55v55855*55 5 v5 5 v#v~ #v#vv#v#v8#v#v*#v #v v#v #v v:V l  xssssssssssssssssssssssssssssssssssss), 5~ 55v55855*5 5 v5 5 v9 / / /  /  agcpxssssssssssssssssssssssssssssssssssssytI-<kd$$Ifl   > N  X "%(~ &v&&8&&*&&&vv xssssssssssssssssssssssssssssssssssss)000044 lagcpxssssssssssssssssssssssssssssssssssssytI-$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l  Pssssssssssssssssssssssss%,55 5*55*59/  / / / / / apPssssssssssssssssssssssssytI-Bkd$$Ifl ִZJVjd 4#& *&*& Pssssssssssssssssssssssss%    44 lapPssssssssssssssssssssssssytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-j$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / /  / /  ap<ytI-j$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / /  / / ap<ytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-\$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l %,55 5*55*59/  / / / / ap<ytI-$$If!vh55 5*55*555#v#v #v*#v#v*#v:V l  Pssssssssssssssssssssssss%,55 5*55*59/ / / / / / apPssssssssssssssssssssssssytI-Bkd$$Ifl ִZJVjd 4#& *&*& Pssssssssssssssssssssssss%    44 lapPssssssssssssssssssssssssytI- $$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V l40*,5*5F5b552 4apytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-$$If!vh5*5F5b552 #v*#vF#vb#v#v2 :V lQ0*5*5F5b552 4aytI-@`@ I-NormalCJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k(No ListHC`H I-Body Text Indenthx^hB'`B I-Comment ReferenceCJaJ6U`6 I- Hyperlink >*B*ph.(`!. I- Line NumberFo2F I-authors19dH^9CJaJoA I-tiFV`QF I-FollowedHyperlink >*B* ph4`b4 I-Header  !4 `r4 I-Footer  !AuDsf4h!"EFoRpRSSHXIXPYQYpftf00,VOtT?T$T,h00d@000@0``00 Գ@00 0 @00 0 PaZRT}T}TD~Tte200a@J0)ݠ004#@h1`00<  00pf&'W^els~=TWXho"#3AHO`i()8DKSdmQ,3;HUfo-6Kvyz&@AMhp{qtu~  Y \ ] l 2 b   = > ? K ` h }  !"-BJ[dEFOW|J &7@145CW_pyz{|6#09%,=Fi"/8t!3<Fcfgnu  :Qi}'8AFW`aQRY`s{k l m !-"/""""""""""# ##**T096H6R6d6u666666666667777;;;;; <G<X<b<l<m<<<<<==="=/=<=I=U=^=k=l=y=z={=|=}=~===========================================8>;>=>@>C>F>I>L>O>R>U>V>>>>>>>>>>>>>>>>>>>>>>>>>??????????? ?/?3?7?>?B?F?I?L?O?S?V?W?X?q?z??????????????@@@@@@@@@ @ @#@%@&@(@*@,@.@0@1@3@5@7@8@S@U@W@X@Y@Z@\@]@_@a@b@c@d@q@r@t@u@v@w@x@y@z@{@|@}@~@@@@@@@@@@@@@@AAA!A#A%A'A*A-A0A3A6A7ARAUAXA[A^AaAdAgAjAmApAsAtAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVBWBpB~BBBBBBBBBBBBBBBBBBBCCCCC C C C'C(C*C+C,C-C.C/C0C=C>C?C@CACBCCCDCECCCCCCCCCCCCCCCCCCCDDD D DDDDDBDDDFDGDHDIDJDKDLD[D^DaDeDhDkDnDqDrDsDtDuDDDDDDDDDDDE8EDEaEjEEEEEEEEEEFF*FpFqFFFFFFF GPOPXPlPPPPPPPPPPQQQ*Q?QGQXQaQRQRoRpR{RRRRRDS^SSSSSSSSST$T-TTTHUIUZUmUtUUUBVVVVVVVVVVVV=WWHXIXVXiXqX~XXYYPYQY`YsYzYYYYZ$Z%Z1ZEZLZ^ZgZZZB[C[R[e[p[}[[[ \C\F\G\S\f\o\\\\\\\\\\\\\\]]!]8]E]]]^^^ ^1^:^?^P^Y^Z^g^^^^^^^_____`#`,`C`T`]``$a%a+a2aEaNa_aha$b>b?bDbKbLbMb`bhbubbbbbbbTccccccccc4dddddd$e_eeeeefmfnfofpfqftf@0)@0)@0@0x@0x @0x@0x @0x @0x @0x @0x @0x @0x@0x @0x@0x@0x @0x@0x @0x @0x @0x@0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x@0x @0x@0x@0x @0x@0x @0x @0x @0x @0x@0x @0x@0x@0x @0x@0x @0x @0x @0x @0x@0x @0x@0x@0x@0x@0x @0x@0x@0x @0x @0x @0x@0x @0x @0x@0x@0x @0x@0x @0x @0x @0x@0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x@0x@0x @0x@0x@0x @0x @0x @0x@0x @0x@0x@0x @0x@0x@0x@0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x@0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x@0x @0x @0x@0x@0x@0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x@0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x @0x@0x @0x @0x @0x@0x @0x @0x@0x@0x@0x@0x@0x@0x @0x@0x @0x @0x @0x @0x @0x@0x@0x@0x@0x@0x@0x@0x @0x@0x@0x@0x@0x@0x@0x @0x @0x @0x @0x @0x@0x@0x@0x@0x@0x@0x @0x @0x @0x @0x@0x @0x @0x@0x@0x @0x @0x @0x @0x@0x@0x@0x @0x @0x@0x@0x@0x@0x@0x@0x@0x @0x @0x @0x @0x@0x @0x @0x@0x@0x @0x @0x @0x @0x@0x@0x@0@0@0 @0@0 @0@0 @0@0 @0@0 @0 @0 @0@0@0@0@0 @0@0@0@0@0 @0@0@0@0@0 @0@0@0@0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@0@0 @0 @0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@0@0@0@0 @0 @0 @0 @0 @0 @0 @0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@0@0@0@0F@0F @0F@0F @0F @0F @0F @0F @0F @0F@0F @0F@0F@0F @0F@0F @0F @0F @0F@0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F@0F @0F@0F@0F @0F@0F @0F @0F @0F @0F@0F @0F@0F@0F @0F@0F @0F @0F @0F @0F@0F @0F@0F@0F@0F@0F @0F@0F@0F @0F @0F @0F@0F @0F @0F@0F@0F @0F@0F @0F @0F @0F@0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F@0F@0F @0F@0F@0F @0F @0F @0F@0F @0F@0F@0F @0F@0F@0F@0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F@0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F@0F @0F @0F@0F@0F@0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F@0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F @0F@0F @0F @0F @0F@0F @0F @0F@0F@0F@0F@0F@0F@0F @0F@0F @0F @0F @0F @0F @0F@0F@0F@0F@0F@0F@0F@0F @0F@0F@0F@0F@0F@0F@0F @0F @0F @0F @0F @0F@0F@0F@0F@0F@0F@0F @0F @0F @0F @0F@0F @0F @0F@0F@0F @0F @0F @0F @0F@0F@0F@0F @0F @0F@0F@0F@0F@0F@0F@0F@0F @0F @0F @0F @0F@0F @0F @0F@0F@0F @0F @0F @0F @0F@0F@0F@0F@0F@0F@0F@0F@0F@0F@0F@0F@0F@0F00pftf00 00pfU u(c8DEFqGcHMII KLL)P\V^gsn8ESasuz}W " H ( K  3 y@pt]>h!JF&4_#,"! g !!##$$%Q's'l(+R>?CbDDEEUFFXGHaHHgIIJJJ K K/K0KDKEKKKKKLLKLLLLLMMpNNvOOOQQ?RcRRRSSTTU*VVX6XXXYoZZ[H]t]^^H`q`Paza%bBcpcFdoddefgg$iEi?jkklsn9;<=>?@ABCDFGHIJKLMNOPQRTUVWXYZ[\]^_`bcdefghijklmnopqrtvwxy{|~rn:##*******+P0R0b05676(7;;<,<B<C<E<sfQQQDQQQQQD8@0(  B S  ?TtTO)TT /TeT$FF==SStfNN==SStf9*urn:schemas-microsoft-com:office:smarttagsplace8*urn:schemas-microsoft-com:office:smarttagsCity i %%01;Xhin#+)0t|{ou{ &*AMv~  6 @ ] d ? C  "%d @J~(5;|9 l}iQ`it}&([fjt8AETk !!%!H"W"##*+96@67!7 <<<<<<<=/=6=<=C=I=O=q?t???????????~BBBBBBBBDDsE~EEEEEEE0F9FqFyFF GwG~GGG.H?HHHHHHI'I-IIIIIIIIIIIIJKK)K:KMKZKtKxKKKLLLLKMVMXM`MMMMMNNNNNNOOOOOOOOPPPPPPaQRpRsRR/S1SDS8T@TBTSTUT]T_TnTTUUUU%UIURUUUUUUUVVgVvVVVV=WWW8X>XXY$Y(YQYXYYYZ#ZgZZZ[%[+[\\G\K\M]j]]]^^^^^^^^__c_t___]`h`l`v`````%a*aaaaaaahbmbccFdVdneyezeeeef ftf'/1VXghnALv}~ d|9h /"7"9""""""""n<v<x<<AAAUBuD}DDDEEEEKKLLLLLLaQ RRCSV<rg| ;p'Z)Rn+ &,u[ZU-7YX0yE: A ? K `  !"-BdEFW| @145CW|69%Ft<cfgu aQR`sk l /""""""# ##H666777;;;;; <G<X<b<l<m<<<<<=="=/=<=I=U=^=k=l=y=z={=|=}=~===========================================8>;>=>@>C>F>I>L>O>R>U>V>>>>>>>>>>>>>>>>>>>>>>>>>??????????? ?/?3?7?>?B?F?I?L?O?S?V?W?X?q?z??????????????@@@@@@@@@ @ @#@%@&@(@*@,@.@0@1@3@5@7@8@S@U@W@X@Y@Z@\@]@_@a@b@c@d@q@r@t@u@v@w@x@y@z@{@|@}@~@@@@@@@@@@@@@@AAA!A#A%A'A*A-A0A3A6A7ARAUAXA[A^AaAdAgAjAmApAsAtAAAAAAAAAAAAAAAAAAAAAAAAAAAVBWBpB~BBBBBBBBBBBBBBBBBBCCCCC C C C'C(C*C+C,C-C.C/C0C=C>C?C@CACBCCCDCECCCCCCCCCCCCCCCCCCCDDD D DDDDDBDDDFDGDHDIDJDKDLD[D^DaDeDhDkDnDqDrDuDDDDDDDDD8EjEEEEEEF*FpFqFFFFb?bMb`bbTcccccc4ddddeeoftf]@pfpf*4pfpfsfP@Unknown Gz Times New Roman5Symbol3& z Arial9 Webdings;Wingdings3@Tunga?5 z Courier New"qh^zF^zFJ'W4J'W4!24=f=f2qHX)?I-2%Electronic file material, ArticlePlusLoretta PickettLoretta Pickett|                       Oh+'0 ,8 X d p|(Electronic file material, ArticlePlusLoretta PickettNormalLoretta Pickett1Microsoft Office Word@@$}@$}J'W՜.+,0$ hp  Dartmouth Medical School4=f' &Electronic file material, ArticlePlus Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./012356789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F߳%}Data 1Table4WordDocumentSummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q